Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia

Preventive Medicine

Volumn 57, Issue SUPPL, 2013, Pages

  Said, Mas Ayu ^a   Hatim, A ^a   Habil, M H ^a   Zafidah, Wan ^b   Haslina, M Y ^b   Badiah, Y ^b   Ramli, M A ^b   Ananjit, S ^c   Sapini, Y ^d   Shah, Mohd ^e   Mahmud, Badli ^f   Bulgiba, Awang ^a   Hairi, Noran N ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b Hospital Permai   (Malaysia)

^c Hospital Bahagia   (Malaysia)

^d Hospital Mesra   (Malaysia)

^e Navy Hospital   (Malaysia)

^f Terendak Army Hospital   (Malaysia)

Author keywords

Antipsychotics; Metabolic syndrome; Monotherapy; Prevalence; Schizophrenia

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; FLUPENTIXOL DECANOATE; FLUPHENAZINE DECANOATE; HALOPERIDOL; OLANZAPINE; PALIPERIDONE; PERPHENAZINE; QUETIAPINE; RISPERIDONE; SULPIRIDE; TRIFLUOPERAZINE;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DSM-IV-TR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MENTAL PATIENT; METABOLIC SYNDROME X; MONOTHERAPY; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT DURATION; WAIST CIRCUMFERENCE;

ANTIPSYCHOTICS; METABOLIC SYNDROME; MONOTHERAPY; PREVALENCE; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; CROSS-SECTIONAL STUDIES; FEMALE; FLUPENTHIXOL; HUMANS; MALAYSIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA; TRIFLUOPERAZINE; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84880602871     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2013.01.005     Document Type: Article

References (14)

1. Anderson P.J., Critchley J.A., Chan J.C., et al. Factor analysis of the metabolic syndrome: obesity vs insulin resistance as the central abnormality. Int. J. Obes. Relat. Metab. Disord. 2001, 25:1782-1788.
2. APA Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR 2000, American Psychiatric Association, Arlington VA. 4th ed.
3. Bobes J., Arango C., Aranda P., Carmena R., Garcia-Garcia M., Rejas J. Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study. Schizophr. Res. 2007, 90:162-173.
4. Cohn T. Obesity and schizophrenia. Medical Illness and Schizophrenia 2009, 61-90. American Psychiatric Press Inc, Arlington VA. J.M. Meyer, H.A. Nasrallah (Eds.).
5. Correll C.U., Frederickson A.M., Kane J.M., Manu P. Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs. J. Clin. Psychiatry 2006, 67:575-583.
6. Falissard B., Mauri M., Shaw K., et al. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs. Int. Clin. Psychopharmacol. 2011, 26:291-302.
7. Fenton W.S., Chavez M.R. Medication-induced weight gain and dyslipidemia in patients with schizophrenia. Am. J. Psychiatry 2006, 163:1697-1704.
8. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
9. Holt R., Abdelrahman T., Hirsch M., et al. The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness. J. Psychopharmacol. 2010, 24:867-873.
10. Kondo T., Osugi S., Shimokata K., et al. Metabolic syndrome and all-cause mortality, cardiac events, and cardiovascular events: a follow-up study in 25,471 young- and middle-aged Japanese men. Eur. J. Cardiovasc. Prev. Rehabil. 2011, 18:574-580.
11. Mcevoy J.P., Meyer J.M., Goff D.C., et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr. Res. 2005, 80:19-32.
12. Meduna L.J., Gerty F.J., Urse V.G. Biochemical disturbances in mental disorders. Arch. Neurol. Psychiatry 1942, 47:38-52.
13. Mohamud W.N., Ismail A.A., Sharifuddin A., et al. Prevalence of metabolic syndrome and its risk factors in adult Malaysians: results of a nationwide survey. Diabetes Res. Clin. Pract. 2011, 91:239-245.
14. Nesto R.W. The relation of insulin resistance syndromes to risk of cardiovascular disease. Rev. Cardiovasc. Med. 2003, 4:11-18.